Placebo RO7269162, RO7269162, RO7269162, RO7269162, FLORBETABEN (18F), FLUTEMETAMOL (18F)
BP44745
Phase 2 small_molecule active
Quick answer
Placebo RO7269162, RO7269162, RO7269162, RO7269162, FLORBETABEN (18F), FLUTEMETAMOL (18F) for Alzheimer’s Disease is a Phase 2 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Alzheimer’s Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active